Document Detail


Intra-arterial targeted islet-specific expression of Sirt1 protects β cells from streptozotocin-induced apoptosis in mice.
MedLine Citation:
PMID:  20842108     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Gene therapy provides a promising approach to curing diabetes. However, an effective route for islet-specific targeting has yet to be established. Toward this end, the pancreatic blood circulation system in Balb/c mice was determined by the injection of rhodamine-containing beads. The efficiency of islet targeting was then measured by the injection of adenoviral vectors carrying a green fluorescence gene via the celiac trunk (C.T.). The results showed that >95% of islets and about 60% of β cells within the pancreatic body and tail could be labeled 3 days after surgery. α-Cell labeling was not as efficient, whereas labeling of nonendocrine tissues was barely detectable. For proof of principle, adenoviral vectors carrying a Sirtuin transgene were injected similarly to test the islet protection effect in the streptozotocin (STZ)-induced type 1 diabetic model. The results demonstrated that overexpression of Sirtuin in STZ-treated mice reduced the level of β-cell death and extent of glucose intolerance. This study reports on efficient islet-specific targeting by using adenoviral injection. This procedure could be invaluable to the treatment of diabetes and the study of islet biology.
Authors:
Mi-mi Tang; Qin-e Zhu; Wen-zhu Fan; Shui-li Zhang; Di-zheng Li; Li-zhong Liu; Miao Chen; Mei Zhang; Jing Zhou; Chi-ju Wei
Related Documents :
6407258 - Effect of a hypoglycaemic sulphonylurea (hb419) and a non-metabolizable amino acid (bch...
8504768 - Experimental diabetes mellitus in a teleost fish. i. effect of complete isletectomy and...
1499868 - Markedly reduced beta-cell function does not result in insulin resistance in islet auto...
6759248 - Islet changes induced by hyperglycemia in rats. effect of insulin or chlorpropamide the...
8750218 - Microvascular function in type 2 (non-insulin-dependent) diabetes: improved vasodilatio...
2680168 - Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-14
Journal Detail:
Title:  Molecular therapy : the journal of the American Society of Gene Therapy     Volume:  19     ISSN:  1525-0024     ISO Abbreviation:  Mol. Ther.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-04     Completed Date:  2011-04-14     Revised Date:  2012-01-04    
Medline Journal Info:
Nlm Unique ID:  100890581     Medline TA:  Mol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  60-6     Citation Subset:  IM    
Affiliation:
Multidisciplinary Research Center, Shantou University, Shantou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoviridae / genetics
Animals
Apoptosis / drug effects*
Blood Glucose / metabolism
Diabetes Mellitus, Experimental / metabolism,  pathology,  therapy*
Gene Therapy / methods*
Genetic Vectors / administration & dosage,  genetics
Glucose Intolerance / therapy
Green Fluorescent Proteins / genetics
Injections, Intra-Arterial
Insulin-Secreting Cells / drug effects*,  metabolism,  pathology
Mice
Mice, Inbred BALB C
Molecular Targeted Therapy / methods
Pancreas / blood supply,  drug effects,  metabolism
Rhodamines / diagnostic use
Sirtuin 1 / biosynthesis*,  genetics
Streptozocin / pharmacology*
Transgenes
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Rhodamines; 147336-22-9/Green Fluorescent Proteins; 18883-66-4/Streptozocin; EC 3.5.1.-/Sirt1 protein, mouse; EC 3.5.1.-/Sirtuin 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis.
Next Document:  Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis ...